2016 Barriers to Cartilage Restoration
Overview
Authors
Affiliations
Cartilage restoration has flourished since the 1990s. The early pioneering work included cell therapy by Peterson, marrow stimulation by Johnson, osteochondral autograft treatments by Hangody, and osteochondral allografts by Gross. Since those early days, many scientists and clinicians have created "variations on a theme", markedly expanding the potential options for treating patients with symptomatic chondral lesions. Nevertheless, a variety of barriers exist between these new cartilage products and their clinical applications. These barriers may be categorized as cost, regulatory, insurance, and logistical issues. While absolute solutions will remain elusive, the current goal is to define these barriers as the first step toward solving these problems.
Charting a quarter-century of commercial cartilage regeneration products.
Liu X, Guo X, Pei Y, Pei M, Ge Z J Orthop Translat. 2025; 50:354-363.
PMID: 39968336 PMC: 11833628. DOI: 10.1016/j.jot.2024.10.009.
Jin Y, Park D, Noh S, Kwon H, Shin D, Park J PLoS One. 2023; 18(5):e0285733.
PMID: 37220126 PMC: 10204946. DOI: 10.1371/journal.pone.0285733.
Surgical management of focal chondral defects of the knee: a Bayesian network meta-analysis.
Migliorini F, Eschweiler J, Schenker H, Baroncini A, Tingart M, Maffulli N J Orthop Surg Res. 2021; 16(1):543.
PMID: 34470628 PMC: 8409000. DOI: 10.1186/s13018-021-02684-z.
Miyahira M, Novaretti J, Astur D, Kaleka C, Amaro J, Cohen M Rev Bras Ortop (Sao Paulo). 2021; 56(3):333-339.
PMID: 34239198 PMC: 8249057. DOI: 10.1055/s-0040-1712493.
Algorithm for Treatment of Focal Cartilage Defects of the Knee: Classic and New Procedures.
Hinckel B, Thomas D, Vellios E, Hancock K, Calcei J, Sherman S Cartilage. 2021; 13(1_suppl):473S-495S.
PMID: 33745340 PMC: 8808924. DOI: 10.1177/1947603521993219.